TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections
- PMID: 22944691
- DOI: 10.1515/hsz-2012-0155
TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections
Abstract
Proteolytic enzymes are involved in almost all biological processes reflecting their importance in health and disease. The human genome contains nearly 600 protease-encoding genes forming more than 2% of the total human proteome. The serine proteases, with about 180 members, built the oldest and second largest family of human proteases. Ten years ago, a novel serine protease family named the type II transmembrane family (TTSP) was identified. This minireview summarizes the up-to-date knowledge about the still growing TTSPs, particularly focusing on the pathophysiological functions of the family member type II transmembrane serine protease (TMPRSS) 4. Recent studies provided important data on TMPRSS4 activity associated with the spreading of influenza viruses, mediated by the cleavage of hemagglutinin. Progression and metastatic potential of several cancers is concordant with an increased expression of TMPRSS4, though being a possible diagnostic marker. However, to benefit from TMPRSS4 as a therapeutic target, more data concerning its physiological relevance are needed, as done by a specific morpholino knockdown in zebrafish embryos.
Similar articles
-
Type II transmembrane serine proteases in cancer and viral infections.Trends Mol Med. 2009 Jul;15(7):303-12. doi: 10.1016/j.molmed.2009.05.003. Epub 2009 Jul 4. Trends Mol Med. 2009. PMID: 19581128 Review.
-
The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.J Virol. 2016 Apr 14;90(9):4298-4307. doi: 10.1128/JVI.02693-15. Print 2016 May. J Virol. 2016. PMID: 26889029 Free PMC article.
-
Role of TMPRSS4 during cancer progression.Drug News Perspect. 2008 Oct;21(8):417-23. doi: 10.1358/dnp.2008.21.8.1272135. Drug News Perspect. 2008. PMID: 19034347 Review.
-
TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.Exp Mol Med. 2023 Apr;55(4):716-724. doi: 10.1038/s12276-023-00975-5. Epub 2023 Apr 3. Exp Mol Med. 2023. PMID: 37009799 Free PMC article. Review.
-
TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.FEBS J. 2010 Dec;277(23):4888-900. doi: 10.1111/j.1742-4658.2010.07894.x. Epub 2010 Oct 26. FEBS J. 2010. PMID: 20977675
Cited by
-
The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction.Front Immunol. 2023 Jul 17;14:1045009. doi: 10.3389/fimmu.2023.1045009. eCollection 2023. Front Immunol. 2023. PMID: 37529051 Free PMC article. Review.
-
Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: correlation with clinicopathological features and prognosis.Med Oncol. 2013 Dec;30(4):749. doi: 10.1007/s12032-013-0749-7. Epub 2013 Oct 17. Med Oncol. 2013. PMID: 24132607
-
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10. Pulm Pharmacol Ther. 2015. PMID: 26166259 Free PMC article.
-
The role of type II transmembrane serine protease-mediated signaling in cancer.FEBS J. 2017 May;284(10):1421-1436. doi: 10.1111/febs.13971. Epub 2016 Dec 24. FEBS J. 2017. PMID: 27870503 Free PMC article. Review.
-
A critical review on serine protease: Key immune manipulator and pathology mediator.Allergol Immunopathol (Madr). 2017 Nov-Dec;45(6):579-591. doi: 10.1016/j.aller.2016.10.011. Epub 2017 Feb 21. Allergol Immunopathol (Madr). 2017. PMID: 28236540 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical